Goldman Sachs maintains Neutral on Angi, lowers target to $6
Goldman Sachs analyst Eric Sheridan maintained a Neutral rating on Angi (NASDAQ: ANGI) and lowered the price target to $6 from $10. This follows a previous Market Perform rating by Citizens analyst Matthew Condon.
*this image is generated using AI for illustrative purposes only.
Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Angi (NASDAQ: ANGI) while lowering the price target to $6 from $10. The revised target reflects a more cautious outlook on the company's stock performance. This adjustment follows a previous Market Perform rating by Citizens analyst Matthew Condon.
Rating Details
The following table outlines the current rating status from Goldman Sachs:
| Company | Ticker | Rating | Price Target |
|---|---|---|---|
| Angi | NASDAQ: ANGI | Neutral | $6 |
What specific factors led Goldman Sachs to adopt a more cautious outlook on Angi's stock performance?
How might this downgrade influence other analysts' ratings and price targets for Angi in the near term?
What are the potential risks or challenges Angi could face that justify the lowered price target?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
